-
Product Insights
IGI Poseidon “Offshore Section” Pipeline
IGI Poseidon "Offshore Section" Pipeline is planned to be constructed in Epirus, Greece. It is expected to be commissioned in 2028. Empower your strategies with our IGI Poseidon "Offshore Section" Pipeline report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on...
-
Product Insights
Image Guided Surgery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Image Guided Surgery Pipeline Market Report Overview Image Guided Surgery devices use real-time images during surgery to assist surgeons in precisely guiding the surgical instruments to the anatomic structures. It helps minimize the chances of errors and reduce the procedure time. The Image Guided Surgery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are...
-
Product Insights
Rotavirus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Rotavirus Infections - Drugs In Development, 2023’, provides an overview of the Rotavirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rotavirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Celiac Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Celiac Disease - Drugs In Development, 2023’, provides an overview of the Celiac Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Celiac Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Helicobacter pylori Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Helicobacter pylori Infections - Drugs In Development, 2023’, provides an overview of the Helicobacter pylori Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Helicobacter pylori Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
EastMed Pipeline
EastMed Pipeline is planned to be constructed in Mediterranean Sea, Israel. It is expected to be commissioned in 2027. Empower your strategies with our EastMed Pipeline report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
Hyundai/ IGIS AM/ Korea South-East Power/ Wijaya Karya – Peusangan-4 Hydroelectric Power Plant 120 MW – Aceh
Equip yourself with the essential tools needed to make informed and profitable decisions with our Hyundai/ IGIS AM/ Korea South-East Power/ Wijaya Karya - Peusangan-4 Hydroelectric Power Plant 120 MW - Aceh report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our...
-
Company Profile
Teligent Inc – Company Profile
Teligent Inc (Teligent), formerly IGI Laboratories Inc, is a specialty generic pharmaceutical company that markets and sells a portfolio of generic pharmaceutical products under its own label and private label to other pharmaceutical companies. The company offers products in topical, injectable and other high-barrier dosage forms. It offers generic topical and generic and branded generic injectable pharmaceutical drugs in the US and Canada. It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic markets. The...
Add to Basket -
Company Profile
IGI Holdings Ltd – Company Profile
IGI Holdings Ltd (IGI), formerly IGI Insurance Ltd, is a multi-line insurance company. It offers a range of life and non-life insurance products to individuals and corporate clients. Its offerings include home insurance, property insurance, travel insurance, health insurance, personal accident insurance, individual life insurance, employee benefits solutions, family takaful solutions, and auto insurance. IGI also offers insurance products for fire, marine cargo, engineering, and individual and group health. It offers pension funds, securities brokerage, money market and foreign exchange...
Add to Basket -
Product Insights
IGI RE – Ashgar City – Giza
Equip yourself with the essential tools needed to make informed and profitable decisions with our IGI RE - Ashgar City - Giza report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the IGI...